Utama › Obesiti › Wilayah Columbia › Washington
Kajian klinikal Obesiti di Washington, DC
33 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The RESET System Pivotal Clinical Trial (Protocol Revision H)
Mengambil peserta
- MedStar Health Research Institute, Washington D.C.
New Heart Imaging Techniques to Evaluate Possible Heart Disease
Mengambil pesertaSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
Mengambil pesertaSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukanMenyebut bayaran untuk peserta
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Hope Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Physical and Behavioral Traits of Overweight and Obese Adults
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Mengambil pesertaFasa 3
- Med Home Development Grp, Washington D.C.
Diabetes and Heart Disease Risk in Blacks
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
- Research Site, Beltsville · 12 mi jauh
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Mengambil pesertaFasa 3
- Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi jauh
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mengambil pesertaFasa 3
- Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi jauh
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Mengambil pesertaFasa 3
- Flourish Research - Bowie, Bowie · 17 mi jauh
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville · 6 mi jauh
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Mengambil pesertaFasa 3
- Research Site, Lanham · 11 mi jauh
- Research Site, Beltsville · 12 mi jauh
Children s Growth and Behavior Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukanMenyebut bayaran untuk peserta
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
Mengambil peserta
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Plant-Based Online Weight Loss Through Education and Resources Program and Study
Mengambil peserta
- Physicians Committee for Responsible Medicine, Washington D.C.
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Children's National Hospital (CNH), Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, Washington D.C.
- AURORA-2 Clinical Site, Bowie · 17 mi jauh
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- Metropolitan Cardiovascular Consultants LLC, Beltsville · 12 mi jauh
- Flourish Bowie, Bowie · 17 mi jauh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 3
- AURORA-1 Clinical Site, Washington D.C.
- AURORA-1 Clinical Site, Bowie · 17 mi jauh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Mengambil pesertaFasa 3
- Emerson Clinical Research Institute, Washington D.C.
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- ACCOMPLISH-2 Research Site, Silver Spring · 7 mi jauh
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
Mengambil pesertaSukarelawan sihat dialu-alukan
- Milken Institute School of Public Health, The George Washington University, Washington D.C.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- The GW Medical Faculty Associates, Washington D.C.
- Flourish Research Bowie, Bowie · 17 mi jauh
Evaluation of Children With Endocrine and Metabolic-Related Conditions
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Prebiotic Inulin for Late-Reproductive Individuals
Mengambil peserta
- Milken Institute School of Public Health, Washington D.C.
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Mengambil pesertaFasa 3
- ACCOMPLISH-1 Research Site, Silver Spring · 7 mi jauh
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Mengambil peserta
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Mechanisms Underlying Individual Variations of Taste and Smell in Obesity
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
MEHMO Natural History and Biomarkers
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Dinner Time for Obesity and Prediabetes
Mengambil pesertaSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Diabetes Reversal Online Program and Study (DROP Study)
Mengambil pesertaSukarelawan sihat dialu-alukan
- Physician Committee for Responsible Medicine, Washington D.C.
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- San Antonio, TX40 kajian
- Orlando, FL32 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD26 kajian
- Jacksonville, FL25 kajian
- St. Louis, MO25 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik43 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Ovari23 kajian
- Limfoma23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.